Elevated platelet activation in patients with atopic dermatitis and psoriasis: Increased plasma levels of β-thromboglobulin and platelet factor 4

Allergology International

Volumn 57, Issue 4, 2008, Pages 391-396

  Tamagawa Mineoka, Risa ^a   Katoh, Norito ^a   Ueda, Eiichiro ^a   Masuda, Koji ^a   Kishimoto, Saburo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Atopic dermatitis; Platelet factor 4; Platelets; Psoriasis; thromboglobulin

Indexed keywords

BETA THROMBOGLOBULIN; IMMUNOGLOBULIN E; LACTATE DEHYDROGENASE; STEROID; THROMBOCYTE FACTOR 4;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; SCORING SYSTEM; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT;

EID: 59549102474     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.O-08-537     Document Type: Article

References (41)

1. Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res 2006;99:1293-304.
2. Knauer KA, Fish JE, Adkindon NF Jr, Lichtenstein LM, Peters SP, Newball HH. Platelets activation in antigen-induced bronchoconstriction. N Engl J Med 1981;305: 892-3.
3. Lupinetti MD, Sheller JR, Catella F, Fitzgerald GA. Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation. Am Rev Respir Dis 1989;140:932-5.
4. Pitchford SC, Yano H, Lever R et al. Platelets are essential for leukocyte recruitment in allergic inflammation. J Allergy Clin Immunol 2003;112:109-18.
5. Averill FJ, Hubbard WC, Proud D, Gleich GJ, Lin MC. Platelets activation in the lung after antigen challenge in a model of allergic asthma. Am Rev Respir Dis 1992;145: 571-6.
6. Coyle AJ, Spina D, Page CP. PAF-induced bronchial hyperresponsiveness in the rabbit: contribution of platelets and airway smooth muscle. Br J Pharmacol 1990;101:31-8.
7. Schmitt-Sody M, Klose A, Gottschalk O et al. Platelet-endothelial cell interactions in murine antigen-induced arthritis. Rheumatology 2005;44:885-9.
8. Andoh A, Tsujikawa T, Hata K et al. Elevated circulating platelet-derived microparticles in patients with active inflammatory bowel disease. Am J Gastroenterol 2005;100: 2042-8.
9. Collins CE, Cahill MR, Newland AC, Rampton DS. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 1994;106:840-5.
10. Vrij AA, Rijken J, Van Wersch JW, Stockbrugger RW. Platelet factor 4 and beta-thromboglobulin in inflammatory bowel disease and giant cell arteritis. Eur J Clin Invest 2000;30:188-94.
11. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005;115:3378-84.
12. Harrison P, Cramer EM. Platelet alpha-granules. Blood Rev 1993; 7:52-62.
13. Boehlen F, Clemetson KJ. Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice? Transfus Med 2001;11:403-17.
14. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004;113:651-7.
15. Leung DY. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000; 105:860-76.
16. Kasperska-Zajac A, Nowakowski M, Rogala B. Enhanced platelet activation in patients with atopic eczema/dermatitis syndrome. Inflammation 2004;28:299-302.
17. McDonald CJ, Calabresi P. Psoriasis and occlusive vascular disease. Br J Dermatol 1978;99:469-75.
18. Ena P, Madeddu P, Glorioso N, Cerimele D, Rappelli A. High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients. Acta Cardiol 1985;40:199-205.
19. Ludwig RJ, Schultz JE, Boehncke WH et al. Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules. J Invest Dermatol 2004; 122:830-6.
20. Hayashi S, Shimizu I, Miyauchi H, Watanabe S. Increased platelet aggregation in psoriasis. Acta Derm Venereol 1985; 65:258-62.
21. Berrettini M, Parise P, Costantini V, Grasselli S, Nenci GG. Platelet activation in psoriasis. Thromb Haemost 1985; 53:195-7.
22. Vila L, Sola J, Puig L, de Castellarnau C, de Moragas JM. Exogenous arachidonic acid metabolism in platelets from psoriatic patients. Acta Derm Venereol 1990;70:110-4.
23. Vila L, Cullaré C, Sola J, Puig L, de Castellarnau C, de Moragas JM. Cyclooxygenase activity is increased in platelets from psoriatic patients. J Invest Dermatol 1991; 97:922-6.
24. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980;92:44-7.
25. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 1993;186:23-31.
26. Ramsay B, Lawrence CM. Measurement of involved surface area in patients with psoriasis. Br J Dermatol 1991; 124:565-70.
27. Kurihara Y, Nakayama H, Nakagawa S. Plasma beta-thromboglobulin and platelet factor 4 in renal insufficiency. Thromb Res 980; 18:557-60.
28. Tamagawa-Mineoka R, Katoh N, Ueda E, Takenaka H, Kita M, Kishimoto S. The role of platelets in leukocyte recruitment in chronic contact hypersensitivity induced by repeated elicitation. Am J Pathol 2007;170:2019-29.
29. Mitsuhashi M, Tanaka A, Fujisawa C et al. Necessity of thromboxane A2 for initiation of platelet-mediated contact sensitivity: dual activation of platelets and vascular endothelial cells. J Immunol 2001;166:617-23.
30. Matsuda H, Ushio H, Geba GP, Askenase PW. Human platelets can initiate T cell-dependent contact sensitivity through local serotonin release mediated by IgE antibodies. J Immunol 1997;158:2891-7.
31. Gear AR, Camerini D. Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 2003;10:335-50.
32. Elsner J, Kapp A. Modulation of eosinophil effector function: the potential role for monoclonal antibodies and chemokine receptor antagonist. Allergy Asthma Proc 2000; 21:345-9.
33. Bruijnzeel PL, Kuijper PH, Rihs S, Betz S, Warringa RA, Koenderman L. Eosinophil migration in atopic dermatitis. I: Increased migratory responses to N-formyl-methionylleucyl-phenylalanine, neutrophil-activating factor, plateletactivating factor, and platelet factor 4. J Invest Dermatol 1993;100:137-42.
34. Hayashi N, Chihara J, Kobayashi Y et al. Effect of platelet-activating factor and platelet factor 4 on eosinophil adhesion. Int Arch Allergy Immunol 1994;104:57-9.
35. Watanabe O, Natori K, Tamari M, Shiomoto Y, Kudo S, Nakamura Y. Significantly elevated expression of PF4 (platelet factor 4) and eotaxin in the NOA mouse, a model for atopic dermatitis. J Hum Genet 1999;44:173-6.
36. Kepner N, Creasy G, Lipton A. Platelets as a source of cell-proliferating activity. In: de Gaetano G, Garattini S (eds). Platelets. New York: Raven Press, 1978;205-12.
37. Rogala B, Gumprecht J, Gluck J. Platelet aggregation in atopic dermatitis. Platelets 1999;10:341-4.
38. Hasegawa S, Pawankar R, Suzuki K et al. Functional expression of the high affinity receptor for IgE (FcεRI) in human platelets and its' intracellular expression in human megakaryocytes. Blood 1999; 93:2543-51.
39. Tomiyama Y, Kunicki TJ, Zipf TF, Ford SB, Aster RH. Response of human platelets to activating monoclonal antibodies: importance of FcγRII (CD32) phenotype and level of expression. Blood 1992; 80:2261-8.
40. Michel L, Dubertret L. Leukotriene B4 and platelet-activating factor in human skin. Arch Dermatol Res 1992; 283:S12-7.
41. Abi-Younes S, Si-Tahar M, Luster AD. The CC chemokines MDC and TARC induce platelet activation via CCR4. Thromb Res 2001; 101:279-89.